Sisters of Those With Adverse Pregnancy Outcome Also Have Increased CVD Risk
By Elana Gotkine HealthDay Reporter
FRIDAY, Feb. 21, 2025 -- Women with adverse pregnancy outcomes (APOs) have an increased risk for cardiovascular disease (CVD), as do their APO-free sisters, according to a study published online Feb. 7 in the European Heart Journal.
Ängla Mantel, M.D., Ph.D., from Karolinska Institute in Stockholm, and colleagues conducted a nationwide population-based cohort study involving primiparous women without prior CVD with registered singleton births between 1992 and 2019. Participants were classified as women with one or more APOs (165,628), APO-free sisters (60,769), and unrelated APO-free comparators (992,108). Participants were followed longitudinally from delivery until 2021 for the primary end point of major adverse cardiac events.
The researchers found that APO-exposed women had increased rates of CVDs relative to APO-free comparators during a median follow-up of 14 years. Compared with APO-free comparators, APO-free sisters had increased adjusted hazard ratios of major adverse cardiac events, heart failure, and cerebrovascular events (adjusted hazard ratios, 1.39, 1.65, and 1.37, respectively); there was no significant increase in ischemic heart disease. Lower CVD rates were seen in APO-free sisters versus their APO-exposed counterparts in a within-family analysis, apart from cerebrovascular events, which did not differ significantly.
"Implementation of tailored preventive strategies for both women with APOs and women with heredity for APOs is paramount in mitigating the heightened CV risk within this vulnerable population," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Specific Antiseizure Medications Associated With Major Malformations in Infants
FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...
ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes
FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...
Increased Risk for CVD Seen for Women With Premenstrual Disorders
THURSDAY, July 17, 2025 -- Women with premenstrual disorders (PMDs) have an increased risk for cardiovascular diseases (CVDs), according to a study published online July 11 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.